Navigation Links
Orchid Cellmark Reports Third Quarter 2008 Financial Results
Date:11/18/2008

to U.K. police forces. These risks and other additional factors affecting these forward-looking statements and Orchid Cellmark's business are discussed under the headings "Risks Related to Our Business" and "Risks Associated with Our Common Stock" in Orchid Cellmark's Annual Report on Form 10-K for the year ended December 31, 2007, as filed with the Securities and Exchange Commission, and in other filings made by Orchid Cellmark with the Securities and Exchange Commission from time to time. Orchid Cellmark expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in Orchid Cellmark's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based, except as may be required by law.

Information contained in our press releases should be considered accurate only as of the date of the release. Information in any press release may be superseded by more recent information we have disclosed in later press releases, filings with the Securities and Exchange Commission or otherwise. Press releases may contain forward-looking statements based on the expectations of our management as of the date of the release. Actual results may materially differ based on several factors, including those described in the press release.

    Contact:
    Investors:                         Media:
    Mary Bashore                       Rick Anderson
    Orchid Cellmark Inc.               The Torrenzano Group
    (609) 750-2324                     (212) 681-1700
    ir@orchid.com                      randerson@torrenzano.com



                    Orchid Cellmark Inc. and Subsidiaries
               Condensed Consolidated Statements of Operations
        Three months and nine months ended Sept
'/>"/>
SOURCE Orchid Cellmark Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Saving the wild orchids of Borneo
2. Orchid Cellmark to Present at the 2008 Bank of America Health Care Conference
3. First orchid fossil puts showy blooms at some 80 million years old
4. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
5. Synaptics Reports Record Results for First Quarter of Fiscal 2009
6. GEN reports on novel tools for deciphering biological networks
7. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
8. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
9. Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
10. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
11. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)..., 2009 Childhood obesity in the United States is ...fourth of advertising on daytime and prime time te...uing questions about the role television plays in ... the Journal of Nutrition Education and Behavior ...ight be a large contributor to the problem. , Re...
(Date:11/4/2009)...., Oct. 19 Spectros, developer and...aging devices which shed light on life-threatening...usive distribution deals for both its T-Stat®...ered include Australia, New Zealand, The Netherla...y, France, Spain, Portugal, Poland, Greece, Turkey...
(Date:11/4/2009)... What,s the cost of saving a teenag...th resulting from prescription medication abuse, t... however, may be unaware that the lock-boxes they,...he ticking timebomb of prescription drugs. That,s ...ty medical supplies, has formed an exclusive partn...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3New biomarker method could increase the number of diagnostic tests for cancer 9054 1New biomarker method could increase the number of diagnostic tests for cancer 9054 2New biomarker method could increase the number of diagnostic tests for cancer 9054 3New biomarker method could increase the number of diagnostic tests for cancer 9054 4LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 1LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 2LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 3LodgeNet Interactive Announces Completion of Offering of 2457 5 Million of Convertible Preferred Stock 50318 4Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 1Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 2Oncology Groups Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program 50315 3
...transplant patients reject their new organs requir...accept or reject each other. Xavier Fernndez-Busqu...y of Barcelona, has found the perfect ally in this...ies that grows abundantly from just north of Cape ...icrociona prolifera) has a cell-to-cell recognitio...
... water is a scene with which we,re all familiar. Y...rable amount of time in the water–polar bears, sea...a thick layer of body fat to keep warm. They rely,...ir fur and the densely packed layer of specially a...scopy and polarizing light microsopy, John W. Weis...
... water is a scene with which we,re all familiar. Y...rable amount of time in the water–polar bears, sea...a thick layer of body fat to keep warm. They rely,...ir fur and the densely packed layer of specially a...scopy and polarizing light microsopy, John W. Weis...
Other Biology News:Simple sea sponge helps scientists understand tissue rejection 2Genome Sequence for Haemophilus Influenzae Completed 2Genome Sequence for Haemophilus Influenzae Completed 3Otter adaptations: How do otters remain sleek and warm 2Otter adaptations: How do otters remain sleek and warm 3
(Date:11/8/2009)...9 Complete Genomics, a third-generation human gen...n of a report in the journal Science describing ... analysis of sequence data from three complete hum...enomes sequenced on the proof-of-principle genomic...e to $1,726 for 45x coverage for the samples descr...
(Date:11/6/2009)... Myriant Technologies LLC ("Myriant"), a privately...wable bio-chemicals, Uhde Corporation of America a...e of the world,s leading engineering contractors (...ineering, procurement & construction (EPC) of ...enewable feedstocks. The execution of this allian...
(Date:11/6/2009)...-- Intarcia Therapeutics, Inc. delivered two prese...uous delivery of exenatide) program for the treatm...s Technology Meeting in San Francisco, CA: ,, (...1/SFTU126LOGO ) ,, Continuous Subcutaneous De...cose, HbA1c and Reduces Weight in a 28-day Phase 1...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...d, CAESAREA, Israel, March 26 Alma Lasers Ltd., ...nd radiofrequency systems,announces important deve...hich is being litigated in the United States Distr...e U.S. Patent and Trademark Office in,Alexandria V...menis,s,patents that are at issue in the litigatio...
...pril 1, 2008, LEVERKUSEN, Germany, and PITTSBURGH...ate MEDRAD, Inc. announced,today that it has succe...ding shares of common stock of Possis Medical, Inc...as advised MEDRAD that, as of the expiration,of th...ay, March 25, 2008,a total of 14,951,550 Possis Me...
...h CyberKnife System to Date, SUNNYVALE, Calif., M...global leader in the field of radiosurgery,announc...fe centers,worldwide are now treating lung cancer ...*. The number of lung cancer patients is growing,s...uals receiving,CyberKnife treatments to date., Lu...
Other Biology Technology:U.S. PTO Reexamining Lumenis Patents 2Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period 2Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 2CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 3CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide 4
Goat Anti-ZBP-89 (S-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Enolase from baker's yeast (S. cerevisiae) from Sigma-Aldrich
UNOsphere S Support, 100 ml from Bio-Rad
Baker's yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
Biology Products: